Articles from Exactice Medical, Inc.

Exactice Medical, Inc. today announced a definitive agreement with ImSonic Medical, Inc. to complete advanced prototype development of its AIM device—the industry’s first combined imaging and transseptal access solution, designed to make transseptal procedures faster, safer, and more cost-effective. Exactice’s proprietary AIM device combines 2D/3D intracardiac echocardiography (ICE) with a fully integrated, deployable steerable needle guide. The needle guide remains continuously within the ultrasound plane of view, eliminating the need for operator coordination of two devices with intermittent visualization. This streamlined design simplifies transeptal access, improves precision targeting of the septum, reduces risk of an off-target puncture, and optimizes procedural workflow. Under this agreement, Exactice secures exclusive rights to develop, commercialize, and distribute ImSonic’s advanced imaging technology as incorporated into the AIM device for use in electrophysiology and interventional cardiology procedures.